Pharma Wealth Boosts Mumbai’s Luxury Real Estate: Blue Jet Healthcare Promoter’s ₹202 Crore Purchase

The promoter of Blue Jet Healthcare and his family have purchased three luxury apartments in Worli, Mumbai, for over ₹202 crore, highlighting the growing trend of pharma wealth flowing into the city’s high-end real estate market.

Real EstateLuxury ApartmentsPharmaceutical WealthMumbaiHighend PropertiesReal EstateAug 08, 2025

Pharma Wealth Boosts Mumbai’s Luxury Real Estate: Blue Jet Healthcare Promoter’s ₹202 Crore Purchase
Real Estate:In a significant move that underscores the growing influence of pharmaceutical wealth in Mumbai’s luxury real estate market, the promoter of Blue Jet Healthcare and his family have acquired three high-end apartments in Worli for over ₹202 crore. According to property registration documents accessed by Zapkey, this purchase is just one of several deals that have marked a surge in pharma investments in Mumbai’s posh neighborhoods.

Akshay Bansarilal Arora, the promoter of Blue Jet Healthcare, bought two units in the super-luxury skyscraper Palais Royale from Honest Shelters Pvt Ltd. Each apartment measures 7,669 sq ft and comes with five car parking spaces, purchased for ₹57.14 crore. Despite the significant transaction, neither Akshay Bansarilal Arora nor Honest Shelters Pvt Ltd could be reached for comment.

In a separate deal, Shiven Akshay Arora, a family member, acquired a 7,747 sq ft apartment in Raheja Artesia, Worli, for ₹88 crore. The residence includes six parking spaces, as per the documents. Shiven Akshay Arora and Raheja could not be reached for comment.

Worli, a central Mumbai locality, has emerged as a hotspot for luxury real estate projects, following the lead of other prime areas like South Mumbai, Lower Parel, Prabhadevi, and Bandra. The micro-market boasts several projects priced above ₹1 lakh per sq ft, making it a prime destination for high-net-worth individuals.

This trend is not unique to the Blue Jet Healthcare family. Other prominent pharmaceutical figures have also made significant investments in Mumbai’s luxury real estate. For instance, USV’s chairperson, Leena Gandhi Tewari, recently bought two luxury sea-facing duplex apartments in Mumbai’s Worli area for ₹639 crore. The transaction, which included ₹63.9 crore in stamp duty and GST, brought the total value to about ₹703 crore, making it the most expensive residential property deal recorded in the country.

The Zydus Family Trust, associated with Zydus Lifesciences Limited, a leading Indian pharmaceutical company, has also purchased a ₹200 crore luxury apartment in Mumbai's Worli earlier this year. Last year, Vibha Shanghvi, the wife of Dilip Shanghvi, chairman and managing director of Sun Pharma, bought two apartments worth ₹130 crore in the same area.

Real estate experts attribute this trend to the post-COVID wealth surge, which has prompted many pharma promoters and executives to view high-end properties as both a secure investment and a status symbol. “Pharma wealth is increasingly flowing into real estate,” said industry experts.

This influx of wealth into the luxury real estate market is expected to continue, driven by the robust performance of the pharmaceutical sector and the increasing preference for premium living spaces among high-net-worth individuals. As more such deals come to light, Mumbai’s luxury real estate market is poised to see further growth and development.

Frequently Asked Questions

What is the total value of the properties purchased by the Blue Jet Healthcare promoter and his family?

The total value of the properties purchased by the Blue Jet Healthcare promoter and his family is over ₹202 crore.

Where are the properties located?

The properties are located in Worli, a central area in Mumbai known for luxury real estate.

Who is the promoter of Blue Jet Healthcare?

The promoter of Blue Jet Healthcare is Akshay Bansarilal Arora.

What other pharmaceutical figures have made significant investments in Mumbai’s luxury real estate?

Other pharmaceutical figures who have made significant investments in Mumbai’s luxury real estate include Leena Gandhi Tewari (USV), the Zydus Family Trust (Zydus Lifesciences), and Vibha Shanghvi (Sun Pharma).

Why are pharmaceutical wealth and investments flowing into luxury real estate?

Pharmaceutical wealth is flowing into luxury real estate due to the post-COVID wealth surge, which has prompted many pharma promoters and executives to view high-end properties as both a secure investment and a status symbol.

Related News Articles

Mumbai's Sky-High Ambitions: Exploring the City's Love for Skyscrapers
Real Estate Mumbai

Mumbai's Sky-High Ambitions: Exploring the City's Love for Skyscrapers

As Mumbai continues to grow

May 30, 2024
Read Article
Mumbai Records Third-Highest Surge in Luxury Housing Prices Globally
real estate news

Mumbai Records Third-Highest Surge in Luxury Housing Prices Globally

Mumbai's prime residential prices surge 11.5% year-on-year, ranking third globally, as India's economic growth drives demand in luxury housing market.

June 29, 2024
Read Article
Affordable Housing Supply Dries Up as Builders Focus on Premium Projects
real estate news

Affordable Housing Supply Dries Up as Builders Focus on Premium Projects

The latest data from JLL India reveals a 21% decline in affordable housing supply below Rs 50 lakh, while premium projects saw a significant surge in demand.

July 15, 2024
Read Article
Priyanka Chopra's Real Estate Empire: A Peek into Her Investments
Real Estate Mumbai

Priyanka Chopra's Real Estate Empire: A Peek into Her Investments

Priyanka Chopra Jonas is a keen investor in the real estate space, owning multiple properties in India and the US. Here's a look at her recent transactions.

July 18, 2024
Read Article
Uber and Heads Up for Tails Expand Pet-Friendly Rides in Delhi and Mumbai
Real Estate Mumbai

Uber and Heads Up for Tails Expand Pet-Friendly Rides in Delhi and Mumbai

Uber has partnered with Heads Up for Tails to offer pet-friendly rides in Delhi and Mumbai, making travel more convenient and comfortable for pet owners.

March 7, 2025
Read Article
Blackstone and Sattva-backed REIT Files Draft Papers for ₹7000 Cr IPO
Real Estate

Blackstone and Sattva-backed REIT Files Draft Papers for ₹7000 Cr IPO

A real estate investment trust (REIT) backed by asset manager Blackstone Group and Bengaluru developer Sattva Group has filed its draft papers with the Securities and Exchange Board of India (SEBI) for a ₹7000 crore initial public offering (IPO).

March 7, 2025
Read Article